Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Segment Reporting [Line Items] | ||||
| Depreciation and amortization | $ 165,188 | $ 177,490 | $ 510,825 | $ 528,645 |
| U. S. Dialysis And Related Lab Services | ||||
| Segment Reporting [Line Items] | ||||
| Depreciation and amortization | 144,360 | 156,242 | 445,991 | 469,923 |
| Other Operating Segment | ||||
| Segment Reporting [Line Items] | ||||
| Depreciation and amortization | $ 20,828 | $ 21,249 | $ 64,834 | $ 58,723 |
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|